Profitability Ratios
| Ratio |
Value |
| GP Margin |
72.0% |
| EBIT Margin |
36.2% |
| EBITDA Margin |
45.2% |
| Operating Margin |
36.2% |
| Pretax Margin |
32.4% |
| Cont. Ops Margin |
28.1% |
| Net Margin |
28.1% |
| Bottom Line Margin |
28.1% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.54 |
| Quick Ratio |
1.30 |
| Solvency Ratio |
0.286 |
| Cash Ratio |
0.51 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
1.81 |
| Forward PEG |
1.81 |
| Price/Book |
5.01 |
| Price/Sales |
4.06 |
| Price/FCF |
21.31 |
| Price/Op Cash Flow |
15.99 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.3692 |
| Debt/Equity |
0.9606 |
| Debt/Capital |
0.4900 |
| Long-Term Debt/Capital |
0.4705 |
| Financial Leverage |
2.60 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
5.08 |
| Operating Cash Flow Ratio |
0.581 |
| Operating Cash Flow/Sales |
25.4% |
| Free Cash Flow/Operating Cash Flow |
75.0% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
6.25 |
| Interest Coverage |
17.3073 |
| Short-Term Operating Cash Flow Coverage |
5.71 |
| Operating Cash Flow Coverage |
0.33 |
| Capital Expenditure Coverage |
4.01 |
| Dividend + Capital Expenditure Coverage |
1.34 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
44.7902% |
| Dividend Yield |
3.1045% |
| Dividend Yield % |
3.1045% |
| Dividend Per Share |
3.2678 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
25.95 |
| EPS |
7.296 |
| Debt/Share |
20.7398 |
| Cash/Share |
5.82 |
| Book Value/Share |
21.05 |
| Tangible BV/Share |
1.76 |
| Equity/Share |
21.03 |
| Operating Cash Flow/Share |
6.584 |
| Capital Expenditure/Share |
1.643 |
| FCF/Share |
4.940 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.866 |
| Earnings Before Tax/EBIT |
0.897 |
| Price/Fair Value |
5.01 |
| Debt/Market Cap |
0.1885 |
| Effective Tax Rate |
13.3% |
| Enterprise Value Multiple |
10.21 |
MRK - Merck & Co., Inc.